D-0714-2022 Class II Terminated

Recalled by Direct Rx — Dawsonville, GA

FDA drug recall D-0714-2022 was initiated by Direct Rx on Dec 7, 2021 and is designated Class II. Reason for recall: Defective Container: Leaking containers. The recall status is terminated (terminated Oct 5, 2023). Affected quantity: 312 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 30, 2022
Initiation Date
Dec 7, 2021
Termination Date
Oct 5, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
312 bottles

Product description

Diclofenac Sodium Topical Solution 1.5%, 150 mL, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534 Mfg. For SOLA Pharmaceuticals Baton Rouge, LA, NDC 61919-675-05

Reason for recall

Defective Container: Leaking containers.

Distribution pattern

Nationwide within the United States

Code information

Lot #: 24MA2010 Exp. 1/31/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0714-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0714-2022. Report a data issue: hello@regdatalab.com.